Correlation Between NYSE Composite and Medtech Acquisition
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Medtech Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Medtech Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Medtech Acquisition Corp, you can compare the effects of market volatilities on NYSE Composite and Medtech Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Medtech Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Medtech Acquisition.
Diversification Opportunities for NYSE Composite and Medtech Acquisition
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between NYSE and Medtech is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Medtech Acquisition Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medtech Acquisition Corp and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Medtech Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medtech Acquisition Corp has no effect on the direction of NYSE Composite i.e., NYSE Composite and Medtech Acquisition go up and down completely randomly.
Pair Corralation between NYSE Composite and Medtech Acquisition
If you would invest 1,925,638 in NYSE Composite on September 14, 2024 and sell it today you would earn a total of 47,299 from holding NYSE Composite or generate 2.46% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 1.56% |
Values | Daily Returns |
NYSE Composite vs. Medtech Acquisition Corp
Performance |
Timeline |
NYSE Composite and Medtech Acquisition Volatility Contrast
Predicted Return Density |
Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Medtech Acquisition Corp
Pair trading matchups for Medtech Acquisition
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Medtech Acquisition as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Medtech Acquisition's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Medtech Acquisition's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Medtech Acquisition Corp.
Pair Trading with NYSE Composite and Medtech Acquisition
The main advantage of trading using opposite NYSE Composite and Medtech Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Medtech Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medtech Acquisition will offset losses from the drop in Medtech Acquisition's long position.NYSE Composite vs. FARO Technologies | NYSE Composite vs. Apogee Therapeutics, Common | NYSE Composite vs. Genfit | NYSE Composite vs. Mind Medicine |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stocks Directory Find actively traded stocks across global markets |